Clinical Trials Directory

Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.

The investigators wish to determine if oral probiotic supplementation during the second half of pregnancy decreases maternal GBS recto-vaginal colonization at 35-37 weeks' gestational age, thereby decreasing need for maternal antibiotic administration at time of labor. The importance of this study is that it may offer a safer alternative to antibiotic treatment of group B Streptococcus (GBS) colonized pregnant women.

Stanford is now accepting new patients for this trial.



  • dietary supplement : Probiotic dietary supplement
  • dietary supplement : Placebo

Phase: Phase 1/Phase 2


Ages Eligible For Study:

18 Years - 55 Years

Inclusion Criteria

1. Pregnant women between 20-28 weeks gestation. 2. 18 years of age or older. 3. Singleton gestation.

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Cynthia Willson, RN

Footer Links: